-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Acadia Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2010 to Q3 2025.
- Acadia Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 169M shares, a 1.72% increase year-over-year.
- Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 166M shares, a 1.16% increase from 2023.
- Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 164M shares, a 1.32% increase from 2022.
- Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 162M shares, a 0.74% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)